330153886	330153886	CD	B-NP	O
|	|	NN	I-NP	O
GXMH	GXMH	NN	I-NP	O
|	|	NN	I-NP	O
04975520	04975520	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
200573	200573	CD	B-NP	O
|	|	CC	I-NP	O
6/11/2000	6/11/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PNEUMONIA	PNEUMONIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/18/2000	9/18/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/13/2000	2/13/2000	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
LEGIONELLA	LEGIONELLA	NNP	B-NP	O
PNEUMONIA	PNEUMONIA	NNP	I-NP	O
,	,	,	O	O
BILATERAL	BILATERAL	NNP	B-NP	O
PLEURAL	PLEURAL	NNP	I-NP	O
EFFUSIONS	EFFUSIONS	NNS	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
THE	THE	DT	B-NP	O
PRESENT	PRESENT	JJ	I-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57-year-old	57-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
distant	distant	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
with	with	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
lupus	lupus	NN	I-NP	O
erythematosus	erythematosus	NN	I-NP	O
features	feature	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
TTP	TTP	NN	B-NP	B-protein
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
splenectomy	splenectomy	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
pleuritic	pleuritic	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
experience	experience	VB	I-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
died	die	VBD	B-VP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
she	she	PRP	B-NP	O
thought	think	VBD	B-VP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
anxiety	anxiety	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
's	's	POS	B-NP	O
death	death	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
and	and	CC	O	O
occurred	occur	VBD	B-VP	O
on	on	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	O	O
says	say	VBZ	B-VP	O
that	that	IN	B-SBAR	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
gradual	gradual	JJ	B-NP	O
onset	onset	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
,	,	,	I-NP	O
non	non	JJ	I-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
month	month	NN	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
fevers	fever	NNS	B-NP	O
up	up	RB	B-PP	O
to	to	TO	B-PP	O
102	102	CD	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
dry	dry	JJ	B-NP	O
heaves	heave	NNS	I-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
and	and	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
has	have	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
intensity	intensity	NN	B-NP	O
and	and	CC	O	O
yesterday	yesterday	NN	B-NP	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
experience	experience	VB	I-VP	O
sharp	sharp	JJ	B-NP	O
pleuritic	pleuritic	JJ	I-NP	O
right	right	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
neck	neck	NN	B-NP	O
stiffness	stiffness	NN	I-NP	O
,	,	,	O	O
photophobia	photophobia	NN	B-NP	O
,	,	,	O	O
sick	sick	JJ	B-NP	O
contacts	contact	NNS	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
recent	recent	JJ	B-NP	O
travel	travel	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
Plaquenil	Plaquenil	NN	B-NP	O
previously	previously	RB	B-ADVP	O
but	but	CC	O	O
she	she	PRP	B-NP	O
self	self	PRP	B-NP	O
discontinued	discontinue	VBD	B-VP	O
this	this	DT	B-NP	O
three	three	CD	I-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
feeling	feel	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
include	include	VBP	B-VP	O
arthritis	arthritis	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
hands	hand	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Past	Past	NNP	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
TTP	TTP	NN	B-NP	B-protein
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
splenectomy	splenectomy	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
Haemophilus	Haemophilus	NNP	B-NP	O
influenzae	influenzae	NNS	I-NP	O
and	and	CC	O	O
pneumococcal	pneumococcal	JJ	B-NP	O
sepsis	sepsis	NN	I-NP	O
,	,	,	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
with	with	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
lupus	lupus	NN	I-NP	O
erythematosus	erythematosus	NN	I-NP	O
features	feature	NNS	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
1989	1989	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
include	include	VBP	B-VP	O
diltiazem	diltiazem	NN	B-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Naprosyn	Naprosyn	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
24	24	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
,	,	,	O	O
Entex-LA	Entex-LA	NNP	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
recently	recently	RB	B-ADVP	O
died	die	VBD	B-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
with	with	IN	B-PP	O
esophageal	esophageal	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
elementary	elementary	JJ	I-NP	O
school	school	NN	I-NP	O
teacher	teacher	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Family	Family	RB	B-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
breast	breast	NN	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
physical	physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98	98	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
100s	100	NNS	I-NP	B-DNA
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
182/99	182/99	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
mild	mild	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
skin	skin	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
rash	rash	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Not	Not	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
neck	neck	NN	I-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
or	or	CC	O	O
thyromegaly	thyromegaly	RB	B-ADVP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Tachycardic	Tachycardic	JJ	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
,	,	,	I-NP	O
gallops	gallop	NNS	I-NP	O
or	or	CC	I-NP	O
rubs	rub	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
lungs	lung	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
and	and	CC	O	O
faint	faint	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Abdominal	Abdominal	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	B-ADJP	O
benign	benign	JJ	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatomegaly	hepatomegaly	NN	I-NP	O
or	or	CC	I-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
scar	scar	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
splenectomy	splenectomy	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
showed	show	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
cords	cord	NNS	I-NP	O
.	.	.	O	O

Negative	Negative	JJ	B-NP	O
Homans	Homan	NNS	I-NP	O
'	'	POS	B-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
neurological	neurological	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-NP	O
laboratory	laboratory	NN	I-NP	O
studies	study	NNS	I-NP	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
137	137	CD	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
19.5	19.5	CD	B-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
bands	band	NNS	I-NP	O
and	and	CC	O	O
86	86	CD	B-NP	O
polys	poly	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Howell-Jolly	Howell-Jolly	JJ	B-NP	O
bodies	body	NNS	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
38.6	38.6	CD	B-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
495	495	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
50	50	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
0	0	CD	B-NP	I-protein
.	.	.	O	O

D-dimer	D-dimer	NN	B-NP	B-protein
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
revealed	reveal	VBD	B-VP	O
large	large	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
limited	limit	VBN	I-NP	O
study	study	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
questionable	questionable	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lung	lung	NN	I-NP	O
versus	versus	IN	B-PP	O
compressive	compressive	JJ	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57-year-old	57-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
distant	distant	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	I-NP	O
TTP	TTP	NN	I-NP	B-protein
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
likely	likely	JJ	B-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-ADJP	O
moderate	moderate	JJ	I-ADJP	O
to	to	TO	B-PP	O
large	large	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
cefuroxime	cefuroxime	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
presumed	presume	VBN	I-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Lasix	Lasix	NNP	B-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
any	any	DT	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
her	her	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
D-dimer	D-dimer	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
spiral	spiral	JJ	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
reveal	reveal	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolus	embolus	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
Dopplers	Doppler	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
continuous	continuous	JJ	I-NP	O
Doppler	Doppler	NNP	I-NP	O
wave	wave	NN	I-NP	O
form	form	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
which	which	WDT	B-NP	O
raised	raise	VBD	B-VP	O
the	the	DT	B-NP	O
suspicion	suspicion	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
proximal	proximal	JJ	I-NP	O
venous	venous	JJ	I-NP	O
compression	compression	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
abdominal	abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
venous	venous	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
lymphatic	lymphatic	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
INFECTIOUS	INFECTIOUS	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
for	for	IN	B-PP	O
what	what	WP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
initially	initially	RB	I-VP	O
be	be	VB	I-VP	O
just	just	RB	B-NP	O
a	a	DT	I-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
with	with	IN	B-PP	O
large	large	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
peripneumonic	peripneumonic	JJ	I-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
cefuroxime	cefuroxime	NN	B-NP	O
and	and	CC	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
General	General	NNP	I-NP	O
Medicine	Medicine	NNP	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
pancultured	panculture	VBN	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
had	have	VBD	B-VP	O
Legionella	Legionella	NNP	B-NP	O
urine	urine	NN	I-NP	O
antigen	antigen	NN	I-NP	O
sent	send	VBN	B-VP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
her	her	PRP$	B-NP	O
Legionella	Legionella	NNP	I-NP	O
urine	urine	NN	I-NP	O
antigen	antigen	NN	I-NP	O
became	become	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
and	and	CC	O	O
repeat	repeat	NN	B-NP	O
test	test	NN	I-NP	O
again	again	RB	B-ADVP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
given	give	VBN	B-PP	O
recommendations	recommendation	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
cefuroxime	cefuroxime	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
as	as	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
thoracentesis	thoracentesis	NN	B-NP	O
late	late	RB	B-NP	O
the	the	DT	I-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
transudate	transudate	NN	I-NP	O
.	.	.	O	O

Cytology	Cytology	NN	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
negative	negative	JJ	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
all	all	DT	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
pleuracentesis	pleuracentesis	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
were	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
large	large	JJ	I-ADJP	O
.	.	.	O	O

Ultrasound	Ultrasound	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
loculations	loculation	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
to	to	TO	I-VP	O
undergo	undergo	VB	I-VP	O
right	right	JJ	B-NP	O
sided	sided	JJ	I-NP	O
ultrasound	ultrasound	JJ	I-NP	O
guided	guided	JJ	I-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
fluid	fluid	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
despite	despite	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
was	be	VBD	B-VP	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
initially	initially	RB	B-NP	O
5	5	CD	I-NP	O
to	to	TO	I-NP	O
6	6	CD	I-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
off	off	RB	B-ADVP	O
of	of	IN	B-PP	O
O2	O2	NN	B-NP	B-protein
except	except	IN	B-PP	O
that	that	IN	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
desaturations	desaturation	NNS	B-NP	O
to	to	TO	B-PP	O
86	86	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
complications	complication	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
included	include	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
800	800	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
acute	acute	JJ	B-NP	O
phase	phase	NN	I-NP	O
reactant	reactant	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
infection	infection	NN	B-NP	O
and	and	CC	I-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
CA-125	CA-125	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
GYN	GYN	NN	I-NP	O
oncologist	oncologist	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
again	again	RB	B-VP	O
should	should	MD	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
resolves	resolve	VBZ	B-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
resolve	resolve	VB	I-VP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
more	more	RBR	B-NP	O
proximal	proximal	JJ	I-NP	O
venous	venous	JJ	I-NP	O
compression	compression	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
reveal	reveal	VB	I-VP	O
any	any	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
p.r.n.	p.r.n.	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
problems	problem	NNS	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
include	include	VBP	B-VP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
times	time	NNS	I-NP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Cardizem-CD	Cardizem-CD	NNP	B-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Michalek	Michalek	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
checked	check	VBD	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
CA-125	CA-125	NN	I-NP	B-protein
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
Legionella	Legionella	NNP	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
resolves	resolve	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
ANDREA	ANDREA	NNP	B-NP	O
MADRUENO	MADRUENO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
GY00	GY00	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CORDELL	CORDELL	NNP	B-NP	O
D.	D.	NNP	I-NP	O
GETER	GETER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JZ62	JZ62	NNP	I-NP	O
LI603/7469	LI603/7469	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
23350	23350	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

F9IX1Z6SXT	F9IX1Z6SXT	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
7/6	7/6	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/1	11/1	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

HARLAND	HARLAND	NNP	B-NP	O
E.	E.	NNP	I-NP	O
GOYNE	GOYNE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QX03	QX03	NNP	I-NP	O

